Terms: = Gastric cancer AND XPO1, DKFZp686B1823, 7514, ENSG00000082898, O14980, CRM1 AND Prognosis
6 results:
1. Transcriptome sequencing and miRNA-mRNA network construction in exosome of macrophage M2 in stomach adenocarcinoma.
Pan D; Li Z; Lin X; Li L
World J Surg Oncol; 2023 Jun; 21(1):193. PubMed ID: 37370118
[TBL] [Abstract] [Full Text] [Related]
2. Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer.
He Y; Mei J; Hao H; Liu F; Yi Y; Hu C; Zou F; Lu X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6931-6941. PubMed ID: 36840755
[TBL] [Abstract] [Full Text] [Related]
3. Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor.
Subhash VV; Yeo MS; Wang L; Tan SH; Wong FY; Thuya WL; Tan WL; Peethala PC; Soe MY; Tan DSP; Padmanabhan N; Baloglu E; Shacham S; Tan P; Koeffler HP; Yong WP
Sci Rep; 2018 Aug; 8(1):12248. PubMed ID: 30115935
[TBL] [Abstract] [Full Text] [Related]
4. Expression of crm1 and CDK5 shows high prognostic accuracy for gastric cancer.
Sun YQ; Xie JW; Xie HT; Chen PC; Zhang XL; Zheng CH; Li P; Wang JB; Lin JX; Cao LL; Huang CM; Lin Y
World J Gastroenterol; 2017 Mar; 23(11):2012-2022. PubMed ID: 28373767
[TBL] [Abstract] [Full Text] [Related]
5. Both high expression of nucleophosmin/B23 and crm1 predicts poorer prognosis in human gastric cancer.
Zhou F; Chen E; You D; Song Y; Sun Z; Yue L
APMIS; 2016 Dec; 124(12):1046-1053. PubMed ID: 27714846
[TBL] [Abstract] [Full Text] [Related]
6. crm1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhou F; Qiu W; Yao R; Xiang J; Sun X; Liu S; Lv J; Yue L
Med Oncol; 2013 Dec; 30(4):726. PubMed ID: 24026662
[TBL] [Abstract] [Full Text] [Related]
